tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ling Wang, 25 are a BUY (92.59%), 2 are a HOLD (7.41%).
Analyst Ling Wang, currently employed carries an average stock price target met ratio of 40.48% that have a potential upside of 40.63% achieved within 322 days. Previously, Ling Wang worked at OPPENHEIMER.
Ling Wang’s has documented 60 price targets and ratings displayed on 7 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on DQ, Daqo New Energy Corp ADR at 24-Sep-2021.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for IMGN (IMMUNOGEN) at 8/27/2010. The price target of $9 was fulfilled within 110 days with a profit of $3.84 (74.42%) receiving and performance score of 6.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$27
1 years 17 days ago
(01-Dec-2023)
4/4 (100%)
$9.83 (57.25%)
134
Hold
$31
$-0.23 (-0.74%)
$26
1 years 17 days ago
(01-Dec-2023)
4/4 (100%)
$1.68 (5.73%)
224
Hold
$31
$-0.23 (-0.74%)
$12
1 years 17 days ago
(01-Dec-2023)
2/2 (100%)
$1.68 (5.73%)
293
Hold
$24
$-7.23 (-23.15%)
$6
1 years 17 days ago
(01-Dec-2023)
5/6 (83.33%)
$-5.32 (-18.14%)
721
Hold
$25
$-6.23 (-19.95%)
1 years 17 days ago
(01-Dec-2023)
4/5 (80%)
$-4.32 (-14.73%)
1442
What Year was the first public recommendation made by Ling Wang?
